Ken Griffin’s Nutex Health NUTX Stock Holding History

Ken Griffin’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,737	Closed	-$839K	–	13688
2025 Q2	$839K	Buy	+6,737	New	+$870K	﹤0.01%	7475
2022 Q3	–	Sell	-1,735	Closed	-$839K	–	13286
2022 Q2	$839K	Buy	+1,735	New	+$2.05M	﹤0.01%	7441

Other funds holding NUTX

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ken Griffin's NUTX Position: Q3 2025 in Review

Ken Griffin sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 6,737 shares — an estimated $839K sold.

Ken Griffin first reported a position in NUTX in Q2 2022 and held it in 2 quarters. The position peaked at $839K in Q2 2022. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

Ken Griffin reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
Ken Griffin sold 6,737 Nutex Health shares in Q3 2025, an estimated $839K.
Ken Griffin first reported a position in Nutex Health in Q2 2022 and held it in 2 quarters.
Ken Griffin's Nutex Health position peaked at $839K in Q2 2022.
95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.